IMB Centre for Superbug Solutions

IMB researchers have investigated a peptide from the marine sandworm, which has the power to kill superbugs.

A new antibiotic, Octapeptin-X that targets the most dangerous drug-resistant bacteria has been given a funding boost by CARB-X.

Bacteria and viruses are all around us - some beneficial and some fatal.

Ian Henderson, Professor of Microbiology, and Dr Larisa Labzin, Virologist, discuss COVID-19 – immunity, vaccine development, epidemiology and what we do and don’t know.

Compounds containing metals could hold the key to the next generation of antibiotics to combat the growing threat of global antibiotic resistance.

IMB has a new Director - Professor Ian Henderson. Ian has devoted his working life to studying antibiotic resistance and develop solutions to this urgent global challenge.

Research into using a cannabis compound as an antibiotic has been boosted by a government grant to an Australian biotech company to collaborate with an Institute for Molecular Bioscience (IMB) superbugs researcher.

New research has opened a pathway to improved antibiotics after revealing a crucial step in the way bacteria construct their defences.

A compound from cannabis has been found to be active against the bacteria responsible for many serious infections such as golden staph and pneumonia. 

In an Australian-first, UQ researchers will join forces with the Global Antibiotic Research and Development Partnership (GARDP) to tackle the growing problem of drug-resistant infections.